Table of Contents

company-logo

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.

Prelude Therapeutics Dividend Announcement

• Prelude Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Prelude Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Prelude Therapeutics Dividend History

Prelude Therapeutics Dividend Yield

Prelude Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Prelude Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Prelude Therapeutics Financial Ratios

P/E ratio-0.56
PEG ratio-0.01
P/B ratio0.47
ROE-66.88%
Payout ratio0.00%
Current ratio7.04
Quick ratio7.04
Cash Ratio0.50

Prelude Therapeutics Dividend FAQ

Does Prelude Therapeutics stock pay dividends?
Prelude Therapeutics does not currently pay dividends to its shareholders.
Has Prelude Therapeutics ever paid a dividend?
No, Prelude Therapeutics has no a history of paying dividends to its shareholders. Prelude Therapeutics is not known for its dividend payments.
Why doesn't Prelude Therapeutics pay dividends?
There are several potential reasons why Prelude Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Prelude Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Prelude Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Prelude Therapeutics a dividend aristocrat?
Prelude Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Prelude Therapeutics a dividend king?
Prelude Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Prelude Therapeutics a dividend stock?
No, Prelude Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Prelude Therapeutics stocks?
To buy Prelude Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Prelude Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.